Latest Merck News & Updates

See the latest news and media coverage for Merck. We track all announcements, press releases, and industry mentions in real time, all in one place.

Merck

Research-intensive biopharmaceutical company

merck.com

Headquarters: Rahway, United States
Company type: Public company
Number of employees: 40,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Merck

In short: Merck outlined a $70 billion pipeline strategy to offset Keytruda's upcoming patent cliff while securing FDA approval for its first oral cholesterol pill.

Company announcements

August 19 Merck

Merck and Moderna report positive Phase 3 melanoma trial results

The INTerpath-001 trial met endpoints for recurrence-free and distant metastasis-free survival with intismeran autogene plus KEYTRUDA.

August 10 Merck

Merck initiates Phase 3 trial for KRAS G12C inhibitor

The KANDLELIT-015 trial evaluates an oral KRAS G12C inhibitor in non-small cell lung cancer, marking the fifth Phase 3 study for this candidate.

August 6 Merck

Merck's sBLA for ENFLONSIA expansion accepted by FDA

EMA also accepted the application for the same population. If approved, children under two at increased risk could receive a second-season dose.

August 4 Merck

Merck announces second-quarter 2026 financial results and pipeline milestones

Sales grew 5% to $16.6B; FDA approved LIPFENDRA and KEYTRUDA combinations; completed $6.8B Terns acquisition.

Media coverage

September 14 Benzinga

Merck Exec Speaking At Morgan Stanley Conference Says Potential 340B And Policy Changes Would Create Tail

https://www.merck.com/events/morgan-stanley-24th-annual-global-healthcare-conference...

September 13 Yahoo Finance

Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results

As dueling data emerge between their drug ivonescimab and a rival Merck medication, Summit and Akeso...

September 12 Fierce Pharma

Merck, Gilead's failed Trodelvy lung cancer trial shows better China results

The fact that Gilead Sciences' Trodelvy failed as a first-line treatm | Newly revealed global phase 3 data from Merck and Gilead's failed Trodelvy first-line...

September 10 Yahoo Finance

Merck Targets $70B Pipeline as It Prepares for KEYTRUDA Exclusivity Loss

Merck & Co., Inc. (NYSE:MRK) executives outlined a strategy centered on pipeline investment, new product launches and targeted business development as the company prepares for...

Never miss news about Merck

Track Merck and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Merck competitors & trending companies

Browse news for competitors to Merck and other trending companies.